PDF

Share on facebook Share on tweeters Share on linkedin Share on googleplus

Theranostics 2022; 12(4):1736-1737. doi:10.7150/thno.70351 This issue Cite

Erratum

Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas: Erratum

Lili Li1,*, Juan Xu1,2*, Guohua Qiu3, Jianming Ying1,4, Zhenfang Du1, Tingxiu Xiang5, Kai Yau Wong6, Gopesh Srivastava6, Xiao-Feng Zhu7, Tony S Mok1, Anthony TC Chan1, Francis KL Chan8, Richard F Ambinder3,9, Qian Tao1,3,9 Corresponding address

1. Cancer Epigenetics Laboratory, Department of Clinical Oncology, State Key Laboratory of Oncology in South China, Sir YK Pao Center for Cancer and Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong;
2. Shenzhen Second People's Hospital, the First Affiliated Hospital of Shenzhen University, Shenzhen, China;
3. Johns Hopkins Singapore, Singapore;
4. Department of Pathology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China;
5. Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China;
6. Department of Pathology, Queen Mary Hospital, The University of Hong Kong;
7. State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China;
8. Institute of Digestive Disease and State Key Laboratory of Digestive Diseases, Department of Medicine and Therapeutics, The Chinese University of Hong Kong;
9. Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore
*Equal Contribution

✉ Corresponding author: Prof Q Tao, Cancer Center, Department of Clinical Oncology, PWH, The Chinese University of Hong Kong, Shatin, Hong Kong. Tel: (852) 3505-1340; Fax: (852) 2648-8842. E-mail: qtaoedu.hk.

Citation:
Li L, Xu J, Qiu G, Ying J, Du Z, Xiang T, Wong KY, Srivastava G, Zhu XF, Mok TS, Chan ATC, Chan FKL, Ambinder RF, Tao Q. Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas: Erratum. Theranostics 2022; 12(4):1736-1737. doi:10.7150/thno.70351. https://www.thno.org/v12p1736.htm
Other styles

File import instruction

Corrected-article in Theranostics, Volume 8, 61

 

In the original publication, errors were found in Fig 3 and Suppl 8A. During the assembling of figures, in Fig 3A, the colony formation assay photos of KYSE150 were misused with re-scanned KYSE510 photos; in Fig 3B and Suppl 8A, the Western blot photos of H1299 were swapped with that of HONE1 for each other. The correct figures are shown below. The authors confirm that these corrections do not change the result interpretation or conclusions of the article. The authors are deeply sorry and sincerely apologize for any inconvenience or misunderstanding that may have caused.

 Figure 1 

Corrected Figure 3 and Suppl. Figure 8.

Theranostics Image

Author contact

Corresponding address Corresponding author: Prof Q Tao, Cancer Center, Department of Clinical Oncology, PWH, The Chinese University of Hong Kong, Shatin, Hong Kong. Tel: (852) 3505-1340; Fax: (852) 2648-8842. E-mail: qtaoedu.hk.

Published 2022-1-21

Citation styles

APA
Li, L., Xu, J., Qiu, G., Ying, J., Du, Z., Xiang, T., Wong, K.Y., Srivastava, G., Zhu, X.F., Mok, T.S., Chan, A.TC., Chan, F.KL., Ambinder, R.F., Tao, Q. (2022). Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas: Erratum. Theranostics, 12(4), 1736-1737. https://doi.org/10.7150/thno.70351.

ACS
Li, L.; Xu, J.; Qiu, G.; Ying, J.; Du, Z.; Xiang, T.; Wong, K.Y.; Srivastava, G.; Zhu, X.F.; Mok, T.S.; Chan, A.TC.; Chan, F.KL.; Ambinder, R.F.; Tao, Q. Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas: Erratum. Theranostics 2022, 12 (4), 1736-1737. DOI: 10.7150/thno.70351.

NLM
Li L, Xu J, Qiu G, Ying J, Du Z, Xiang T, Wong KY, Srivastava G, Zhu XF, Mok TS, Chan ATC, Chan FKL, Ambinder RF, Tao Q. Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas: Erratum. Theranostics 2022; 12(4):1736-1737. doi:10.7150/thno.70351. https://www.thno.org/v12p1736.htm

CSE
Li L, Xu J, Qiu G, Ying J, Du Z, Xiang T, Wong KY, Srivastava G, Zhu XF, Mok TS, Chan ATC, Chan FKL, Ambinder RF, Tao Q. 2022. Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas: Erratum. Theranostics. 12(4):1736-1737.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use